#BREAKING 40% of Kyiv population without power after Russian strikes: mayor pic.twitter.com/E81LPdtMlq
— AFP News Agency (@AFP) December 29, 2022
Cabaletta Bio Wins FDA Fast Track Designation for CABA-201
Cabaletta Bio, Inc. (NASDAQ:CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today announced that the
